Simplex Trading’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Simplex Trading’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-24	Closed	-$1K	–	9478
2025 Q2	$1K	Buy	+24	New	+$1.56K	﹤0.01%	8332
2024 Q1	–	Sell	-162	Closed	-$10K	–	9299
2023 Q4	$10K	Buy	+162	New	+$9.52K	﹤0.01%	7425
2023 Q1	–	Sell	-309	Closed	-$19K	–	9506
2022 Q4	$19K	Buy	+309	New	+$18.6K	﹤0.01%	6917
2020 Q4	–	Sell	-72	Closed	-$3K	–	8661
2020 Q3	$3K	Buy	+72	New	+$3.88K	﹤0.01%	7286
2019 Q1	–	Sell	-36	Closed	-$1K	–	7427
2018 Q4	$1K	Buy	+36	New	+$1.84K	﹤0.01%	6750
2018 Q3	–	Sell	-2,049	Closed	-$103K	–	7695
2018 Q2	$103K	Buy	+2,049	New	+$102K	﹤0.01%	4252

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Simplex Trading's IHE Position: Q3 2025 in Review

Simplex Trading sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2025, closing a stake of 24 shares — an estimated $1K sold.

Simplex Trading first reported a position in IHE in Q2 2018 and held it in 6 quarters. The position peaked at $103K in Q2 2018. 149 funds tracked by Wall St. Rank hold IHE as of Q3 2025.

Simplex Trading reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2025 after selling out during the quarter.
Simplex Trading sold 24 iShares US Pharmaceuticals ETF shares in Q3 2025, an estimated $1K.
Simplex Trading first reported a position in iShares US Pharmaceuticals ETF in Q2 2018 and held it in 6 quarters.
Simplex Trading's iShares US Pharmaceuticals ETF position peaked at $103K in Q2 2018.
149 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.